Search for: "Teva Pharmaceuticals"
Results 961 - 980
of 1,429
Sort by Relevance
|
Sort by Date
10 Mar 2011, 3:18 pm
Teva Pharmaceuticals USA, Inc., Civ. [read post]
9 Mar 2011, 3:00 am
Bayer AG (FDA Law Blog) (Patent Docs) Melatonin – EWCA refers SPC questions to the ECJ: Neurim Pharmaceuticals (1991) Ltd v Comptroller General of Patents (The SPC Blog) (The SPC Blog) (EPLAW) (IPKat) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
8 Mar 2011, 7:54 am
Generic versions of Topamax, known generally as topiramate, are sold by Teva Pharmaceuticals, Watson Pharmaceuticals, and Mylan as well as other generic drug companies. [read post]
24 Feb 2011, 1:49 pm
Teva Pharmaceuticals, 726 F. [read post]
24 Feb 2011, 2:40 am
Ineos Healthcare Ltd v Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) (Teva Pharmaceutical Industries Ltd, other party) (Case T-222/09); [2011] WLR (D) 53 “In opposition proceedings against registration of a trade mark pursuant to article 42 of Council Regulation (EC) No 40/94, the opposing party was not obliged to adduce evidence in support of the opposition. [read post]
21 Feb 2011, 4:29 am
The company's chief operating officer reportedly said of the suit that he has no idea what the company did wrong.The second of those cases was that of the $500 million punitive damages award against Teva Pharmaceutical Industries, upon which we reported back in May as appearing to be a case of misplaced anger. [read post]
15 Feb 2011, 5:26 pm
: Ineos Healthcare v OHMI – Teva (Class 46) Androderm (Testosterone) – US: Watson settles with Promote Innovation in Androderm false marking suit (Patent Docs) Asacol (Mesalamine) – US: Roxane sanctioned in Asacol patent dispute with Medeva (Patent Docs) Detrol (Tolterodine) – US: Subsequent ANDA sponsor says Detrol LA patent has gotta go; But would a final court decision trigger 180-day exclusivity? [read post]
10 Feb 2011, 5:35 pm
As a first applicant, Teva qualified for 180-day exclusivity. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
4 Feb 2011, 2:28 pm
Teva argues that C&C standard encourages applicant to conceal prior art. [read post]
2 Feb 2011, 3:52 am
Highlights this week included: India, South Africa gain from J&J generic deal, Patent Pool loses out (Spicy IP) (KEI) Advair (Fluticasone propionate, Salmeterol) – Netherlands: GSK reverse on Dutch Advair patent and SPC (The SPC Blog) (The SPC Blog) (Kluwer Patent Blog) Brazilian Attorney General of the Union restricts ANVISA’s role in pharmaceutical patent review (PatentlyBIOtech) Please join the discussion by adding your comments on any of these stories, and please do let… [read post]
28 Jan 2011, 11:38 am
Teva Pharmaceuticals USA, Inc., C.A. [read post]
25 Jan 2011, 10:58 pm
Cephalon (Patently-O) Seroquel (Quetiapine) – UK: Teva launches High Court action to revoke AstraZeneca’s European patent (IP Factor) Synagis – US: PDL BioPharma Synagis patent invalidated: Medimmune v PDL BioPharma (Patent Docs) Tarka (Trandolapril, Verapamil) – US: Glenmark loses jury verdict in DNJ over Tarka (IPBiz) Wechol (Colesevelam) – US: Watson confirms Welchol oral suspension patent challenge (SmartBrief) [read post]
24 Jan 2011, 8:19 pm
., Teva Pharmaceutical Industries, and UDL Laboratories, Inc. [read post]
23 Jan 2011, 10:35 am
Reuters reports: Israel's Teva Pharmaceutical Industries has launched a High Court action in London to revoke the European patent for Seroquel, an anti-depressant [used in cases of schizophrenia and bipolar] developed by AstraZeneca The US Hatch-Waxman case over Seroquel (quetiapine) began in DNJ in 2005. [read post]
21 Jan 2011, 6:38 am
Senate (see our previous posts here and here) critical of the Agency’s recent characterization of the 12-year reference product exclusivity period provided by the Biologics Price Competition and Innovation Act of 2009 (“BPCIA”) as “marketing exclusivity” rather than “data exclusivity,” several generic drug manufacturers (Hospira, Momenta Pharmaceuticals, Hospira, Mylan Labs, Teva Pharmaceuticals, and Watson… [read post]
19 Jan 2011, 2:00 am
Highlights this week included: Sensipar (Cinacalcet) – US: District Court Delaware: Obviousness type double patenting does not require later-issued patent with shorter term to abridge term of earlier-granted patent with longer term: Brigham and Women’s Hospital et al v Teva et al (Docket Report) (PatLit) Tarka (Trandolapril / Verapamil) – US: District Court New Jersey: Sanofi, Abbott win trial over Glenmark’s generic Tarka (GenericsWeb) (IPBiz) Please join the… [read post]
16 Jan 2011, 9:48 pm
The manufacturers that filed the appeals case were: Teva Pharmaceutical Industries, Mylan Inc.'s UDL Laboratories and Actavis Inc. [read post]
12 Jan 2011, 6:55 am
Teva Pharmaceuticals USA Inc., et. al., 1-08-cv-00464 (DED January 7, 2011, Order) (Bartle, C.J.) [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
